These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 17266884)
1. [Overexpression and prognostic value of p53 and HER2/neu proteins in benign ovarian tissue and in ovarian cancer]. Coronado Martín PJ; Fasero Laiz M; García Santos J; Ramírez Mena M; Vidart Aragón JA Med Clin (Barc); 2007 Jan; 128(1):1-6. PubMed ID: 17266884 [TBL] [Abstract][Full Text] [Related]
2. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients. Korkolis DP; Tsoli E; Fouskakis D; Yiotis J; Koullias GJ; Giannopoulos D; Papalambros E; Nikiteas NI; Spiliopoulou CA; Patsouris E; Asimacopoulos P; Gorgoulis VG Anticancer Res; 2004; 24(3b):2061-8. PubMed ID: 15274401 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer. Wang D; Zhu H; Ye Q; Wang C; Xu Y Medicine (Baltimore); 2016 Feb; 95(8):e2803. PubMed ID: 26937910 [TBL] [Abstract][Full Text] [Related]
5. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma]. Li JD; Li MD; Li YF; Huang X; Liu JH; Liu FY; Zhang CQ Ai Zheng; 2002 Mar; 21(3):292-6. PubMed ID: 12451998 [TBL] [Abstract][Full Text] [Related]
7. Expression of p53 and HER2/Neu in Kenyan Women With Primary Ovarian Carcinoma. Mutuiri AP; Nzioka A; Busarla SV; Sayed S; Moloo Z Int J Gynecol Pathol; 2016 Nov; 35(6):537-543. PubMed ID: 26825003 [TBL] [Abstract][Full Text] [Related]
8. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors. Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733 [TBL] [Abstract][Full Text] [Related]
9. Two types of primary mucinous ovarian tumors can be distinguished based on their origin. Simons M; Simmer F; Bulten J; Ligtenberg MJ; Hollema H; van Vliet S; de Voer RM; Kamping EJ; van Essen DF; Ylstra B; Schwartz LE; Wang Y; Massuger LF; Nagtegaal ID; Kurman RJ Mod Pathol; 2020 Apr; 33(4):722-733. PubMed ID: 31695154 [TBL] [Abstract][Full Text] [Related]
11. Multivariate analyses of DNA index, p62c-myc, and clinicopathological status of patients with ovarian cancer. Curling M; Stenning S; Hudson CN; Watson JV J Clin Pathol; 1998 Jun; 51(6):455-61. PubMed ID: 9771445 [TBL] [Abstract][Full Text] [Related]
12. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma. Ali-Fehmi R; Che M; Khalifeh I; Malone JM; Morris R; Lawrence WD; Munkarah AR Cancer; 2003 Oct; 98(7):1423-9. PubMed ID: 14508829 [TBL] [Abstract][Full Text] [Related]
13. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis. Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872 [TBL] [Abstract][Full Text] [Related]
14. [Expression of hSef and FGF-2 in epithelial ovarian tumor]. Feng QL; Shi HR; Qiao LJ; Zhao J Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):770-4. PubMed ID: 22335910 [TBL] [Abstract][Full Text] [Related]
15. Value of P-glycoprotein, glutathione S-transferase pi, c-erbB-2, and p53 as prognostic factors in ovarian carcinomas. van der Zee AG; Hollema H; Suurmeijer AJ; Krans M; Sluiter WJ; Willemse PH; Aalders JG; de Vries EG J Clin Oncol; 1995 Jan; 13(1):70-8. PubMed ID: 7799045 [TBL] [Abstract][Full Text] [Related]
16. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma. Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146 [TBL] [Abstract][Full Text] [Related]